Apao•AAO Joint Congress, Bali 2009 May 16 -19, 2009.

dc.contributor.authorSatriah, Ismail
dc.date.accessioned2022-09-13T07:55:41Z
dc.date.available2022-09-13T07:55:41Z
dc.date.issued2009
dc.description.abstractTo report our experience in a patient with severe vernal shield ulcer treated with a combination of surgical debridement of the ulcer, supratarsal injection of triamcinolone acetonide, topical cyclosporine 0.05% and ketotifen fumerate 0.025%. Method: A patient with severe, resistant shield ulcer who did not res-pond to medical treatment with topical steroids, mast cell stabilizers and antihistamines was treated with surgical debridement of the ulcer, supratarsal injection of tria111Cinolone acetonide, topical cyclosporine 0.05% and ketetifen fumarate 0.025%. Results: The ulcer healed. well after three weeks. Topical cyclosporine was discontinued after two months. The patient was symptom free with no recurrence for six months. Conclusion: Combination of surgical debridemenr· of the ulcer, supratarsal injection of triamc!nolone acetonide, topical cyclosporine 0.05% and ketotifen fumerate 0.025% are effective as the treatment option in managing patient with severe vernal shield ulcer. Chronic use of topical steroid can be avoided.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/16063
dc.publisherPusat Pengajian Sains Kesihatanen_US
dc.subjectOur experience in a patient with severe vernal shield ulcer treated with a combination of surgical debridement of the ulceen_US
dc.titleApao•AAO Joint Congress, Bali 2009 May 16 -19, 2009.en_US
dc.typeOtheren_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: